A novel technique of antimicrobial photodynamic therapy - aPDT using 1,9-dimethyl-methylene blue zinc chloride double

Darcy de A Santos1, Pedro Jorge L Crugeira2, Iago P F Nunes3

  • 1Center of Health Science, Federal University of the Reconcavo Bahiano, Carlos Amaral Ave, 1015 - Cajueiro, Santo Antônio de Jesus, BA CEP: 44.574-490, Brazil; Center of Biophotonics, Federal University of Bahia, 62, Araujo Pinho Ave, Canela, Salvador, BA 40110-150, Brazil.

Insights

Antimicrobial photodynamic therapy (aPDT) using 1,9-Dimethyl-Methylene Blue Zinc Chloride Double Salt (DMMB) and polarized light effectively reduced Staphylococcus aureus in vitro. This study demonstrates aPDT

Area of Science:

  • Biochemistry
  • Photochemistry
  • Microbiology

Background:

  • Antimicrobial resistance necessitates alternative infection treatments.
  • Antimicrobial Photodynamic Therapy (aPDT) offers a promising alternative to antibiotics.
  • 1,9-Dimethyl-Methylene Blue Zinc Chloride Double Salt (DMMB) is a potent photosensitizer for aPDT.

Purpose of the Study:

  • To evaluate the in vitro efficacy of aPDT against Staphylococcus aureus.
  • To assess the effectiveness of DMMB combined with polarized light for aPDT.

Main Methods:

  • In vitro assessment of aPDT against Staphylococcus aureus (ATCC 25923).
  • Utilized varying concentrations of DMMB (150 and 300 ng/mL) with polarized light.
  • Quantified colony-forming units (CFUs) after incubation to determine bacterial reduction.

Main Results:

  • Significant exponential reduction in Staphylococcus aureus CFUs observed.
  • Achieved 99.93% reduction with 150 ng/mL DMMB and 10 J/cm² polarized light.
  • Achieved 99.97% reduction with 300 ng/mL DMMB and 5 J/cm² polarized light.

Conclusions:

  • aPDT using DMMB and polarized light is highly efficacious against Staphylococcus aureus in vitro.
  • The study confirms the potential of DMMB-based aPDT as an alternative antimicrobial strategy.

Related Concept Videos